Literature DB >> 9756746

Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori.

N Nagahara1, Y Akiyama, M Nakao, M Tada, M Kitano, Y Ogawa.   

Abstract

In an effort to augment the anti-Helicobacter pylori effect of amoxicillin, mucoadhesive microspheres, which have the ability to reside in the gastrointestinal tract for an extended period, were prepared. The microspheres contained the antimicrobial agent and an adhesive polymer (carboxyvinyl polymer) powder dispersed in waxy hydrogenated castor oil. The percentage of amoxicillin remaining in the stomach both 2 and 4 h after oral administration of the mucoadhesive microspheres to Mongolian gerbils under fed conditions was about three times higher than that after administration in the form of a 0.5% methylcellulose suspension. The in vivo clearance of H. pylori following oral administration of the mucoadhesive microspheres and the 0.5% methylcellulose suspension to infected Mongolian gerbils was examined under fed conditions. The mucoadhesive microspheres and the 0.5% methylcellulose suspension both showed anti-H. pylori effects in this experimental model of infection, but the required dose of amoxicillin was effectively reduced by a factor of 10 when the mucoadhesive microspheres were used. In conclusion, the mucoadhesive microspheres more effectively cleared H. pylori from the gastrointestinal tract than the 0.5% methylcellulose suspension due to the prolonged gastrointestinal residence time resulting from mucoadhesion. A dosage form consisting of mucoadhesive microspheres containing an appropriate antimicrobial agent should be useful for the eradication of H. pylori.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756746      PMCID: PMC105867     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.

Authors:  N Chiba; B V Rao; J W Rademaker; R H Hunt
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

Review 2.  Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease.

Authors:  D Y Graham
Journal:  J Gastroenterol Hepatol       Date:  1991 Mar-Apr       Impact factor: 4.029

Review 3.  The role of acid inhibition in the treatment of Helicobacter pylori infection.

Authors:  A T Axon
Journal:  Scand J Gastroenterol Suppl       Date:  1994

Review 4.  NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

Authors: 
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

5.  A 1-h topical therapy for the treatment of Helicobacter pylori infection.

Authors:  K Kimura; K Ido; K Saifuku; Y Taniguchi; K Kihira; K Satoh; T Takimoto; Y Yoshida
Journal:  Am J Gastroenterol       Date:  1995-01       Impact factor: 10.864

6.  Local gastric and serum amoxicillin concentrations after different oral application forms.

Authors:  M P Cooreman; P Krausgrill; K J Hengels
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

7.  In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative.

Authors:  Y Akiyama; N Nagahara; T Kashihara; S Hirai; H Toguchi
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

8.  Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers.

Authors:  E Bayerdörffer; S Miehlke; G A Mannes; A Sommer; W Höchter; J Weingart; W Heldwein; H Klann; T Simon; W Schmitt
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

9.  Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.

Authors:  G D Bell; K U Powell; S M Burridge; G Spencer; G Bolton; K Purser; S Brooks; S Prosser; G Harrison; P W Gant
Journal:  Aliment Pharmacol Ther       Date:  1992-12       Impact factor: 8.171

Review 10.  Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence.

Authors:  G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1994-08       Impact factor: 8.171

View more
  13 in total

1.  Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.

Authors:  Guofei Dai; Ni Cheng; Lei Dong; Mutsumi Muramatsu; Shudong Xiao; Ming-Wei Wang; De-Xu Zhu
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.

Authors:  R B Umamaheshwari; Suman Ramteke; Narendra Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2004-04-07       Impact factor: 3.246

3.  Stomach-specific controlled release gellan beads of acid-soluble drug prepared by ionotropic gelation method.

Authors:  Mrunalini Narkar; Praveen Sher; Atmaram Pawar
Journal:  AAPS PharmSciTech       Date:  2010-02-24       Impact factor: 3.246

4.  Sustained release of amoxicillin from ethyl cellulose-coated amoxicillin/chitosan-cyclodextrin-based tablets.

Authors:  Kultida Songsurang; Jatuporn Pakdeebumrung; Narong Praphairaksit; Nongnuj Muangsin
Journal:  AAPS PharmSciTech       Date:  2010-12-15       Impact factor: 3.246

5.  In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.

Authors:  T Kanamaru; Y Nakano; Y Toyoda; K I Miyagawa; M Tada; T Kaisho; M Nakao
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 6.  Gastroretentive drug delivery systems for the treatment of Helicobacter pylori.

Authors:  Shan Zhao; Yan Lv; Jian-Bin Zhang; Bing Wang; Guo-Jun Lv; Xiao-Jun Ma
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

7.  Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori.

Authors:  Saahil Arora; Sankalp Gupta; Raj K Narang; Ramji D Budhiraja
Journal:  Sci Pharm       Date:  2011-05-19

8.  Formulation and evaluation of floating oral in situ gelling system of amoxicillin.

Authors:  Dasharath M Patel; Divyesh K Patel; Chhagan N Patel
Journal:  ISRN Pharm       Date:  2011-07-28

9.  Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres.

Authors:  Sree Harsha
Journal:  Int J Nanomedicine       Date:  2012-09-04

10.  Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization.

Authors:  Sree Harsha
Journal:  Drug Des Devel Ther       Date:  2013-09-26       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.